SEC Form 4 · accession 0001424422-15-000011
BioPharmX Corp · BPMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen Morlock
Director
Period of report
Apr 30, 2015
Accepted (ET)
May 1, 2015 · 5:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001504167
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase common stockF1 | $3.00 | Apr 30, 2015 | A | 50,000 | A | Apr 30, 2015 | Apr 30, 2025 | Common stock | 50,000 | 50,000 | D |
Explanation of responses
- F1This option vests ratably over 24 months with the first vesting starting on 4/30/15.